Suboxone | Addiction Professional Magazine Skip to content Skip to navigation

Suboxone

Timing uncertain on introduction of generic Suboxone film

June 18, 2018  |  Gary A. Enos, Editor
news
Two companies have received federal approval to market generic versions of Suboxone film, but ongoing patent litigation could slow their arrival to the market.

Separate unit for opioid disorder treatment builds fellowship

May 7, 2018  |  Gary A. Enos, Editor
article
Caron Treatment Centers responded to patient concerns about isolation by establishing a treatment unit devoted exclusively to opioid use disorders.

Study explores challenge of initiating patient on injectable naltrexone

April 17, 2018  |  Gary A. Enos, Editor
article
New research offers hope for those who might assume it is too difficult to transition an opioid-dependent patient to injectable naltrexone in a community-based setting.

First non-opioid to treat withdrawal clears key hurdle

April 13, 2018  |  Alison Knopf, Contributing Writer
article
An advisory committee to the Food and Drug Administration (FDA) is recommending approval of lofexidine, which would offer an alternative to opioid medications for treatment of opioid withdrawal symptoms.

SAMHSA grants will encourage wider access to naloxone

April 12, 2018  |  Gary A. Enos, Editor
news
Methadone treatment programs and buprenorphine prescribers are among those eligible for federal grants to encourage wider distribution of opioid overdose reversal drugs.

Respect, not coddling, for buprenorphine patients

April 11, 2018  |  Sylvester Sviokla, MD
article
A physician in recovery sees patients soar with an assist from buprenorphine.

Conference highlights Connecticut's pacesetting medication treatment in prisons

March 14, 2018  |  Gary A. Enos, Editor
article
A plenary session at the conference of the American Association for the Treatment of Opioid Dependence (AATOD) featured a look at signs of progress in the correctional and insurance arenas.

No time for petty conflict amid an opioid crisis

March 12, 2018  |  Gary A. Enos, Editor
article
The opening session of the American Association for the Treatment of Opioid Dependence (AATOD) conference emphasized putting to rest old internal conflicts about treatment.

SCE: Be open to evidence-based treatment

March 9, 2018  |  Julie Miller, Editor in Chief
article
Experts speaking in Chicago at the Summit For Clinical Excellence, The Opioid Crisis: Strategies for Treatment and Recovery covered a number of treatment modalities that clinicians might not be embracing just yet.

Research pinpoints areas with serious provider shortage to combat opioid crisis

February 27, 2018  |  Gary A. Enos, Editor
article
An analysis comparing buprenorphine provider capacity and opioid overdose deaths identifies significant provider shortages in the Mid-Atlantic and Midwest regions.

Nurses, peers pivotal to health system's opioid disorder initiative

February 12, 2018  |  Gary A. Enos, Editor
article
Leaders at Christiana Care Health System say efforts to identify and address opioid use disorders in hospital settings should not be confined to the emergency room.

FDA approves once-monthly injectable buprenorphine product

December 1, 2017  |  Tom Valentino, Senior Editor
article
The FDA has approved a once-monthly injectable form of buprenorphine for the treatment of opioid use disorder, but clinicians are lukewarm on its use.

Pages

Subscribe to Suboxone